Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer: A Fading Effect?

被引：17

作者：

Besse, Benjamin ^{[1
]}

Le Chevalier, Thierry ^{[1
,2
]}

机构：

[1] Inst Gustave Roussy, Dept Med, Villejuif, France

[2] Glaxo SmithKline, Res & Dev Oncol, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 31期

关键词：

D O I：

10.1200/JCO.2008.18.1081

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5014 / 5017

页数：4

共 26 条

[11]

Le Chevalier T, 2008, J CLIN ONCOL, V26, p398s

[12]

Lord RVN, 2002, CLIN CANCER RES, V8, P2286

[13] Revisions in the International System for Staging Lung Cancer [J].

Mountain, CF .

CHEST, 1997, 111 (06) :1710-1717

[14] DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy [J].

Olaussen, Ken A. ;

Dunant, Ariane ;

Fouret, Pierre ;

Brambilla, Elisabeth ;

Andre, Fabrice ;

Haddad, Vincent ;

Taranchon, Estelle ;

Filipits, Martin ;

Pirker, Robert ;

Popper, Helmut H. ;

Stahel, Rolf ;

Sabatier, Laure ;

Pignon, Jean-Pierre ;

Tursz, Thomas ;

Le Chevalier, Thierry ;

Soria, Jean-Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) :983-991

[15] Global cancer statistics, 2002 [J].

Parkin, DM ;

Bray, F ;

Ferlay, J ;

Pisani, P .

CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108

[16]

PIGNON JP, J CLIN ONCOL

[17] Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial [J].

Rosell, R ;

Gatzemeier, U ;

Betticher, DC ;

Keppler, U ;

Macha, HN ;

Pirker, R ;

Berthet, P ;

Breau, JL ;

Lianes, P ;

Nicholson, M ;

Ardizzoni, A ;

Chemaissani, A ;

Bogaerts, J ;

Gallant, G .

ANNALS OF ONCOLOGY, 2002, 13 (10) :1539-1549

[18] End points for colon cancer adjuvant trials: Observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 Randomized trials from the ACCENT group [J].

Sargent, Daniel J. ;

Patiyil, Smitha ;

Yothers, Greg ;

Haller, Daniel G. ;

Gray, Richard ;

Benedetti, Jacqueline ;

Buyse, Marc ;

Labianca, Roberto ;

Seitz, Jean Francois ;

O'Callaghan, Christopher J. ;

Francini, Guido ;

Grothey, Axel ;

O'Connell, Michael ;

Catalano, Paul J. ;

Kerr, David ;

Green, Erin ;

Wieand, Harry S. ;

Goldberg, Richard M. ;

de Gramont, Aimery .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) :4569-4574

[19] Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer [J].

Scagliotti, GV ;

Fossati, R ;

Torri, V ;

Crinó, L ;

Giaccone, G ;

Silvano, G ;

Martelli, M ;

Clerici, M ;

Cognetti, F ;

Tonato, M .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19) :1453-1461

[20] Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592:: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy [J].

Schiller, JH ;

Adak, S ;

Feins, RH ;

Keller, SM ;

Fry, WA ;

Livingston, RB ;

Hammond, MEM ;

Wolf, B ;

Sabatini, L ;

Jett, J ;

Kohman, L ;

Johnson, DH .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :448-457

← 1 2 3 →